Ameritas Investment Partners’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | – | Sell |
-30
| Closed | -$9K | – | 3131 |
|
2021
Q1 | $9K | Hold |
30
| – | – | ﹤0.01% | 2892 |
|
2020
Q4 | $11K | Hold |
30
| – | – | ﹤0.01% | 2747 |
|
2020
Q3 | $9K | Hold |
30
| – | – | ﹤0.01% | 2764 |
|
2020
Q2 | $11K | Hold |
30
| – | – | ﹤0.01% | 2671 |
|
2020
Q1 | $7K | Hold |
30
| – | – | ﹤0.01% | 2680 |
|
2019
Q4 | $16K | Hold |
30
| – | – | ﹤0.01% | 2513 |
|
2019
Q3 | $13K | Hold |
30
| – | – | ﹤0.01% | 2615 |
|
2019
Q2 | $36K | Hold |
30
| – | – | ﹤0.01% | 2102 |
|
2019
Q1 | $37K | Hold |
30
| – | – | ﹤0.01% | 2050 |
|
2018
Q4 | $28K | Hold |
30
| – | – | ﹤0.01% | 2139 |
|
2018
Q3 | $43K | Hold |
30
| – | – | ﹤0.01% | 2073 |
|
2018
Q2 | $48K | Buy |
+30
| New | +$48K | ﹤0.01% | 2006 |
|
2017
Q2 | – | Sell |
-8
| Closed | -$4K | – | 3014 |
|
2017
Q1 | $4K | Buy |
+8
| New | +$4K | ﹤0.01% | 2870 |
|